Since the estrogen receptor (ER) status is the most important marker in defining the prognosis and treatment of breast cancer, the correlation of POSTN expression with overall survival and disease free survival was analysed in ER-positive and ER-negative subgroups. This evidence concerns the gene POSTN and breast cancer.